ELECTROCARDIOGRAPHIC ALTERNANS, a phenomenon of beat-tobeat oscillation in electrocardiographic waveforms, was first described by Hering in 1908 (35) . Much of the interest in the alternans phenomenon has focused on alternans during the repolarization phase of the cardiac action potential (AP), also known as repolarization alternans (RA). More specifically, RA, as measured by clinical microvolt T-wave alternans (MTWA) testing, has been associated with an increased risk for ventricular tachyarrhythmic events (VTEs) and sudden cardiac death (SCD) across a wide range of pathophysiological conditions (6, 8) . Cardiac alternans can also be produced in structurally normal hearts under conditions of chronotropic stimulation (48, 81) or significant metabolic stress (38) .
RA has traditionally been associated with arrhythmic risk during medium-and long-term follow-up (53) . Recently, however, several lines of preclinical and clinical data suggest that surges in RA may also be closely associated with acute arrhythmia susceptibility (61, 85, 87) and that states of heightened RA may play a causative or permissive role in creating the electrophysiological substrate necessary for arrhythmogenesis.
Mechanisms of Alternans in Isolated Myocytes
Two major hypotheses have been implicated in the mechanism of alternans at the cellular and subcellular level.
The first hypothesis is based on the association between cellular alternans and alternation in sarcolemmal currents, membrane voltage, and AP morphology, which then leads secondarily to beat-to-beat fluctuations in intracellular calcium concentration ([Ca 2ϩ ] i ). In support of this hypothesis, it has recently been shown that the modulation of sarcolemmal Ca 2ϩ (52) and K ϩ (23, 37) currents due to changes in AP morphology (42) has a significant effect on the stability of Ca 2ϩ handling processes (2) . Alternatively, the second hypothesis suggests that alternation of [Ca 2ϩ ] i is the primary event which then secondarily leads to alternans of membrane voltage and AP morphology (19, 20, 31, 38, 42, 47, 64, 65) .
According to the second hypothesis, [Ca 2ϩ ] i alternans can result from stress-induced perturbations in any number of Ca 2ϩ transport processes including Ca 2ϩ entry into the cytoplasm, recovery of ryanodine receptors (RyRs) from inactivation, triggering of sarcoplasmic reticulum (SR) Ca 2ϩ release, SR Ca 2ϩ uptake, intra-SR Ca 2ϩ redistribution and linking of intracellular Ca 2ϩ handling to surface membrane voltage (53) . Under certain circumstances alternans at the cellular level may be driven primarily by voltage dynamics (23) , however, a preponderance of recent data has emerged in support of the second hypothesis, suggesting the primacy of perturbations in Ca 2ϩ handling processes as the fundamental event in the genesis of cellular alternans.
We have shown that elevated SR Ca 2ϩ content results in both aberrant SR Ca 2ϩ release and [Ca 2ϩ ] i alternans and also gives rise to an inward depolarizing current that results in subthreshold early afterdepolarizations and AP duration (APD) prolongation which correlates directly with the magnitude and timing of the aberrant Ca 2ϩ release (3, 4) . These findings are in agreement with results suggesting that RyRs are more likely to be triggered by cytosolic Ca 2ϩ when SR lumenal Ca 2ϩ is elevated (33, 40, 51) and that increasing SR Ca 2ϩ content increases spontaneous SR Ca 2ϩ release (73) and delayed afterdepolarization (DAD) amplitude toward the threshold to trigger an AP (44, 63, 78, 88) . Furthermore, triggered activity arising from DADs in response to high stimulation rates (67) or to catecholamines has been demonstrated in normal ventricular myocytes (69) , experimental heart failure preparations (68) , and cardiomyopathic human hearts (29) .
In that context, it is hypothesized that in the normal heart, calcium-induced calcium release is manifest by an operational baseline [Ca 2ϩ ] SR that is lower than the threshold to trigger spontaneous Ca 2ϩ release (Fig. 1) . However, high stimulation frequency or ␤-adrenergic stimulation trigger SR Ca 2ϩ overload that raises the SR Ca 2ϩ baseline level above the threshold at which spontaneous subthreshold Ca 2ϩ release may occur. In the diseased heart, although the baseline SR Ca 2ϩ level is decreased, the [Ca 2ϩ ] SR-threshold for RyR opening is also decreased. Although ␤-adrenergic responsiveness is impaired in the diseased heart (11), even a moderate residual or transient ␤-adrenergic responsiveness (68) ] i ). The presence of subcellular spatially discordant alternans has been associated with increased dispersion of subcellular electrophysiological properties and, in the setting of an appropriate trigger, may lead to an arrhythmia at the cellular level (89) . In addition to arrhythmia at the cellular level, via coupling between [Ca 2ϩ ] i and membrane voltage, the presence of subcellular spatially discordant alternans may also contribute to APD alternans at the tissue level by initiating triggered activity and inducing subtle changes in APD (89) .
In support of the concept of subcellular spatially discordant alternans, it is also possible that dynamic regulation of sarcoplasmic reticulum Ca 2ϩ -ATPase 2a, Na ϩ /Ca 2ϩ exchanger, and RyR function by metabolic and ionic factors in the microdomain of the SR (1, 12, 14, 82, 90, 91) leads to dynamic fluctuations in SR Ca 2ϩ uptake and release, particularly in the diseased heart (68, 83, 89) . This dynamic regulation may lead to spatial heterogeneity of thresholds for the onset of alternans in different regions of the myocyte (1, 89) and perpetuate the state of subcellular spatially discordant alternans. Although preexisting heterogeneities in calcium-cycling components in different areas of the myocyte, as may occur in diseased myocytes, may contribute to subcellular differences in the threshold for alternans onset (1), purely dynamic mechanisms that do not depend on preexisting heterogeneities, such as Turing-type instabilities, have also been proposed (11, 12, 27) . Thus the pathophysiological mechanism of subcellular spatially discordant alternans is likely governed by an interplay of anatomic and dynamic heterogeneities.
These data suggest that in the diseased heart, cellular alternans requires a trigger event (such as increased ␤-stimulation or a Ca 2ϩ wave) and an appropriate subcellular substrate to develop. Increasing the probability of RyR opening alone does not produce arrhythmogenic Ca 2ϩ release due to an accompanying decrease in SR Ca 2ϩ content. ␤-Adrenergic stimulation increases SR Ca 2ϩ content and thereby allows the increased RyR open probability to produce Ca 2ϩ release (83) . A trigger event alone may be sufficient to induce alternans in the normal heart, since it requires supraphysiological heart rates to create a heterogeneous (fragmented) subcellular Ca 2ϩ release profile. In the diseased heart, however, perturbations in the intracellular calcium cycling machinery create a sufficiently heterogeneous subcellular substrate leading to the development of alternans at lower heart rates and predisposing to arrhythmogenesis.
Based on this evidence, it is conceivable that following cardiac "injury," during the remodeling phase of the heart, the compensatory increase in ␤-adrenergic stimulation results in progressively increased SR Ca 2ϩ content and a higher proba- Fig. 1 . Theoretical paradigm for differential mechanisms of alternans in the normal and diseased heart. In the normal heart, the calcium content in the sarcoplasmic reticulum at baseline ([Ca 2ϩ ]SR-base) is lower than the threshold required to elicit alternans ([Ca 2ϩ ]SR-th). ␤-Adrenergic stimulation (␤-stim) in the normal heart increases the baseline SR calcium content; however, the calcium concentration remains below that required for alternans. In the diseased heart, although the threshold of SR calcium content for alternans induction is lower than in the normal heart, the baseline SR calcium content is also lower and so alternans is not present at baseline. However, in a diseased heart, an appropriate trigger event (i.e., ␤-stim) can increase the baseline SR calcium content to a level above the threshold for alternans induction.
bility of inducing alternans. Although in end-stage heart failure the loss of ␤-adrenergic responsiveness is almost complete (11) , in moderate cardiomyopathy, it is likely that residual ␤-adrenergic responsiveness results in higher [Ca 2ϩ ] SR content and spontaneous SR Ca 2ϩ release (68) . As the heart transitions from the compensatory phase to clinical heart failure, cardiac remodeling progresses to the point that the slope of the released SR Ca 2ϩ -SR Ca 2ϩ content relationship is steep enough that despite the loss of ␤-adrenergic responsiveness (11), transient/ residual ␤-adrenergic responsiveness (68) may result in higher [Ca 2ϩ ] SR content, increased incidence of fractionated and aberrant SR Ca 2ϩ release and Ca 2ϩ waves, and higher probability of alternans occurrence (Fig. 2) .
Mechanisms of Alternans in the Intact Heart
As discussed above, alternation in [Ca 2ϩ ] i has emerged as the primary determinant of alternans at the cellular and subcellular level, which then leads to a secondary alternation of APD.
In a manner analogous to subcellular Ca 2ϩ heterogeneities, optical mapping studies in the whole heart have also demonstrated the presence of localized [Ca 2ϩ ] i alternans induced by ischemia (70) or pacing (86) , which then evolve to occupy larger regions within the heart. Choi and Salama (15) have proposed that heterogeneities of refractory period play a critical role in the initiation and maintenance of electrical alternans induced by an increase in heart rate, and Ca 2ϩ alternans is a consequence of alternations in AP upstroke velocity resulting in alternations of calcium current, SR Ca 2ϩ release, and Ca 2ϩ recycling, whereas ischemia-induced alternans are elicited by abnormalities in Ca 2ϩ handling. The transition from concordant to discordant alternans has been observed to occur via two different pathways: first, as the cycle length decreases, the regions displaying spatially concordant alternans become larger, and the instantaneous transition to discordant alternans occurs; second, the transition to discordant alternans occurs over time during adaptation (57) . The local onset of [Ca 2ϩ ] i alternans precedes the local onset of APD alternans (86) , and heterogeneities of APD do not necessarily correlate with the onset of alternans (57), again supporting the primacy of Ca 2ϩ cycling instabilities in the genesis of alternans, even in the intact heart.
Optical mapping in normal hearts has also shown that discordant APD alternans (reflecting two adjacent areas of the myocardium that oscillate with opposite phase) is associated with a state of marked cardiac electrical instability, as evidenced by the fact that when ventricular fibrillation occurred following APD alternans, it has only been observed following discordant, but not concordant, APD alternans. This unstable electrical substrate is consistently induced at a critical heart rate threshold and is largely independent of the pacing site (48) , suggesting that it is caused by heterogeneities of cellular repolarization properties and not heterogeneous propagation delay. Furthermore, alternans most commonly involves the slope of the AP plateau and the onset of final repolarization, timing during calcium-induced calcium release that coincides with the timing of aberrant RyR release during alternans observed by our group (3) and others (20) . Thus, if myocytes in a region of tissue synchronously develop Ca 2ϩ waves (24) , resulting in subcellular alternans, it is possible that the amplitude and the phase of APD alternans in that region may change relative to the surrounding tissue, thus increasing dispersion of APD and generating a potentially arrhythmogenic substrate.
The progression from subcellular Ca 2ϩ instabilities to tissuelevel arrhythmia is also critically dependent on the strength of cellular coupling. Cell-to-cell coupling via gap junctions results in a myocardial syncytium that tends to have a homogenizing effect on instabilities in isolated myocytes due to the source-sink effect, particularly when those instabilities are driven primarily by voltage dynamics. In contrast, heterogeneities in [Ca 2ϩ ] i are more likely to result in spatiotemporal propagation due to the slower diffusion constant of Ca 2ϩ across gap junctions. However, Jia et al. (41) have demonstrated that rather than depending directly on the Ca 2ϩ diffusion constant, the strength of intracellular coupling between membrane voltage and [Ca 2ϩ ] i and intercellular coupling of membrane voltage serves as the primary determinant of alternans propagation. Furthermore, conditions which lead to uncoupling of intercellular conductance (i.e., myocardial ischemia) reduce the threshold for propagation of both concordant and discordant alternans, a condition that can be reversed with rotigaptide, a novel antiarrhythmic that enhances gap junction conductance (46) . In summary, it appears that AP alternans begins in a localized area in the heart and gives rise to microvolt level alternans (77) . When this region of AP alternans extends to a significant portion of the myocardium (such that it is large enough to overcome the 3-dimensional current sink problem) and becomes sufficiently synchronous, it can then be seen on the surface electrocardiogram (ECG) as RA (49) . Localized alternation in APD in turn is associated with delayed recovery on an every other beat basis, resulting in spatial dispersion of recovery, fractionation of depolarization wave fronts, and setting the stage for the development of reentry and arrhythmia onset (8, 64, 71) .
RA and Acute Clinical Arrhythmia Susceptibility
MTWA testing has traditionally been used as a marker of medium-and long-term risk of VTEs and SCD. T-wave alternans represents an alternating fluctuation in the morphology of (16, 30) , it seems likely that MTWA is not as good a predictor of "appropriate" ICD therapy as it is a predictor of spontaneous VTE/SCD in patients without ICDs (36, 55, 56) . This discrepancy is likely due in part to the fact that "appropriate" ICD therapy is a relatively poor surrogate for SCD (22) . In studies where a relatively small percentage (i.e., Յ15%) of patients are implanted with ICDs, MTWA testing remains a strong predictor of VTE/SCD (36) , and in a pooled analysis of over 2,800 patients without ICDs, the 2-year risk of SCD among patients with a nonnegative MTWA test was over fourfold higher than patients with a negative test result (55) . Despite the potentially confounding effect of ICDs in recent MTWA studies, the aggregate of clinical data strongly supports the notion that an increased magnitude of RA, as detected by MTWA testing, is closely associated with the substrate that gives rise to VTE/SCD over medium and long-term follow-up.
However, recent clinical observations have also suggested that heightened RA may be an important predictor of shortterm arrhythmia susceptibility. Analysis of ambulatory bodysurface electrograms (Holter monitors) from patients with coronary artery disease has demonstrated a sharp upsurge in RA magnitude (measured by time-domain techniques) within minutes before spontaneous VTE (76) . In this study, TWA amplitude reached a peak about 10 min before the onset of ventricular arrhythmia with a peak magnitude about 25% higher than during a mean baseline obtained 60 to 120 min before the VTE.
Sharp upsurges in T-wave alternans immediately preceding spontaneous ventricular arrhythmias have also been documented from body-surface ECGs (leads V1, V5, and aVF) in patients hospitalized for acute heart failure (62) . In this study, TWA increased from a baseline of 18.6 Ϯ 2.1 to 27.9 Ϯ 4.6 V (P Ͻ 0.05) during the 15 to 30 min before arrhythmia onset and remained elevated until the occurrence of VTE. Results were similar across all three body surface leads.
Although the magnitude of surges in TWA measured from body-surface leads is less than that measured from intracardiac electrograms (EGMs), the aforementioned data support the idea that significant increases in T-wave alternans before the onset of spontaneous VTE can be measured from body-surface electrodes and may be used to predict acute arrhythmia susceptibility (Fig. 3) . However, given the significantly larger magnitude of RA measured from intracardiac EGMs, it seems likely that the use of intracardiac data will provide a much more robust assessment of the link between surges in RA and acute arrhythmogenesis. Importantly, simultaneous measurement of RA from body-surface and intracardiac electrograms by our group (87) and others (66) has shown a high degree of correlation, suggesting that these measurements are detecting the same electrical phenomenon.
Analysis of intracardiac EGMs from ICDs has demonstrated a sharp increase in RA magnitude immediately before spontaneous ventricular arrhythmias (5, 45, 80) . However, a similar upsurge in RA has not been observed before induced ventricular arrhythmias or preceding inappropriate ICD shocks (45) . A recent prospective, multicenter study has extended these observations by analyzing intracardiac EGMs from patients with ICDs (79) . In this study, because of the limited number of beats stored by the ICD before the onset of the VTE, repolarization dynamics were estimated using a simple averaging method that measures both alternans and nonalternans T-wave variability (TWA/V). Although this method is less specific for determining alternans periodicity than the better validated spectral-analytic method, given the significantly larger amplitude of T-wave alternans measured from ICD shock electrograms compared with body-surface ECGs, the simple averaging method can provide a measure of T-wave dynamics without extensive signal processing and with a limited number of beats to analyze before arrhythmia onset. In this study, the magnitude of TWA/V immediately before VTE was compared with four control data segments: baseline rhythm, rapid pacing (at 105 beats/min), time-matched ambulatory EGMs from the same time of day at which spontaneous VTE occurred, and EGMs before supraventricular tachycardia onset. The magnitude of TWA/V before spontaneous VTE was significantly greater than during any of the four control data segments. Furthermore, in logistic regression models, each 10-V increase in TWA/V was associated with an increase in odds of VTE of 2.2. These data show a close temporal association between surges in TWA/V and onset of spontaneous ventricular arrhythmias. To date, the preponderance of data linking surges in RA to acute arrhythmia susceptibility has focused on ventricular arrhythmias. However, several lines of evidence also suggest that RA may play an important role in the onset of atrial arrhythmias. The onset of APD alternans has been closely linked with the transition from atrial flutter or atrial pacing to atrial fibrillation (59, 60) .
In aggregate, several lines of evidence support the idea that surges in RA, measured either from body-surface or intracardiac electrodes, are closely associated with an increase in acute ventricular, and potentially atrial arrhythmia susceptibility. These data suggest that the heart either passes through a state of heightened RA on the way to ventricular tachycardia/ ventricular fibrillation (VT/VF) or heightened RA occurs in close conjunction with developing VT/VF (64, 65) . In either scenario, these findings suggest that detecting significantly elevated levels of RA may serve as an important short-term predictor of impending arrhythmias and also raise the possibility of using upstream therapies to abort VT/VF before arrhythmia onset.
Utility of RA to Guide Therapy
RA in vivo is known to be a spatially and temporally heterogeneous phenomenon (74) , and therefore, any attempt to deliver upstream suppressive therapy is predicated on the ability to accurately detect alternans regardless of where in the heart it originates. Our group has identified a novel lead configuration for the optimal spatiotemporal detection of intracardiac RA, using the spectral technique [more details on this method can be found in Weiss et al. (87) ]. In Fig. 4A we demonstrate the sharp surge in two indexes of RA, alternans voltage and K score (87) , during balloon occlusion of the left circumflex coronary artery in a swine model. Alternans voltage reflects the beat-to-beat amplitude fluctuation during cardiac repolarization, whereas the K score is a measure of the statistical significance of the alternans voltage (72) . To determine which intracardiac lead combination is most sensitive for RA detection, in Fig. 4B we present the probability that a far-field bipolar intracardiac lead configuration is positive for RA, given that at least one intracardiac far-field lead is positive, for each of the right ventricle (RV), coronary sinus (CS), left ventricle (LV), epicardial, and triangular RV-CS far-field intracardiac lead configuration. When an intracardiac lead is positive for RA, the probability that the triangular RV-CS lead is positive is 85.5%, greater than any other intracardiac lead, suggesting that this lead configuration may provide an optimal approach for intracardiac RA detection.
In Fig. 5 , we demonstrate the use of the triangular RV-CS lead configuration to detect temporal surges in RA, following balloon occlusion of the left circumflex coronary artery in the same model. Although there are dynamic fluctuations in RA magnitude during coronary ischemia, the level of RA remains significantly elevated compared with that of baseline during the first 5 min of the recording. Importantly, there is also a marked surge in RA immediately before the onset of ventricular fibrillation. Therefore, there is significant evidence to support the idea that the novel RV-CS lead configuration can be used to reliably detect surges of RA immediately before the onset of spontaneous ventricular arrhythmias. The use of the RV-CS lead configuration also has important clinical applicability since many currently used implantable devices (i.e., cardiac resynchronization therapy platforms) already employ RV and CS leads.
The ability to detect heightened levels of RA from implantable intracardiac devices opens the door to the possibility of delivering upstream therapy to suppress RA and prevent a favorable substrate for arrhythmogenesis from developing. Upstream therapy also has the important potential benefit of preventing the need for ICD shocks, which have an adverse impact on quality of life and may also have a detrimental effect on heart failure disease progression (13, 58) .
Various forms of upstream therapy (27, 28) have been proposed including adaptive pacing protocols (9, 17, 18) that might be incorporated into existing implantable device plat- ) and Kscore (red line) are plotted for a single study subject. Both alternans voltage and Kscore significantly increase beginning 175 s after balloon occlusion, reflecting an increasingly unstable electrophysiological substrate. B: probability that a far-field bipolar intracardiac lead is positive for repolarization alternans (RA), given that at least one intracardiac far-field lead is positive for RA, for each of the right ventricle (RV), coronary sinus (CS), left ventricle (LV), epicardium (EPI), and triangular RV-CS far-field intracardiac lead configurations (87) . The RA-positive percentage in RV-CS was *statistically significantly larger than for the RV configuration (P ϭ 0.040), the CS configuration (P ϭ 0.004), and the LV configuration (P ϭ 0.035), but not for the EPI configuration (P ϭ 0.270), suggesting that RA detection from a far-field RV-CS bipolar lead provides the optimal sensing vector for intracardiac alternans detection.
forms such that if the device detects an unstable myocardial substrate (as evidenced by heightened RA magnitude), the adaptive pacing protocol would be activated to deliver electrical therapy to restabilize the electrical substrate so that even if a trigger event occurred (i.e., a premature beat), that trigger would no longer encounter a vulnerable electrical substrate and the onset of arrhythmia would be prevented. The adaptive pacing protocol could be terminated when the RA magnitude falls below a predetermined threshold. Prior studies have investigated the use of dynamic pacing protocols based on real-time measurement of APD to control alternans. Simulation studies in one-dimensional cable geometry have suggested that RA control is limited to a maximum cable length due to the formation of standing wave patterns of alternans (21) . In vitro studies have used dynamic pacing protocols based on real-time measurement of APD to control RA in small sections of bullfrog myocardium (34) , canine Purkinje fibers (17) and perfused canine RV preparations (43), demonstrating alternans control over a region of tissue as large as ϳ2-2.5 cm. However, these studies were limited in controlling alternans in spatially constrained models. The only in vivo demonstration of dynamic pacing therapy to control alternans, demonstrated control of atrioventricular nodal conduction alternans in 5 patients undergoing clinically-indicated electrophysiology studies (18) . However, atrioventricular nodal conduction alternans remains a spatially limited phenomenon and does not recapitulate the complex spatial-temporal nature of alternans during ventricular repolarization. Therefore, the ability to control ventricular alternans, in vivo, in the diseased heart has been elusive until recently.
Data from our group on the use of adaptive pacing to suppress RA are presented in Fig. 6 . Using the acute coronary artery occlusion model in swine (as detailed in Figs. 4 and 5) , in panel a significant alternans is visible during acute ischemia as evidenced by significantly heightened levels of alternans voltage (Fig. 6A ) and K score (Fig. 6B) . In panel b, adaptive pacing is delivered on an every other beat basis from electrodes in the RV (RV12) with the following parameters: amplitude of ϩ4 mA; pulse width of 10 ms; pulse coupling to the R wave of 10 ms. R wave triggered pacing during the absolute refractory period on every even beat results in a significant reduction of spontaneous TWA during acute ischemia (alternans voltage, ϳ7-fold average reduction compared with baseline in panel a, P Ͻ 0.000001; and K score , ϳ43-fold average reduction compared with baseline in panel a, P Ͻ 0.000001). In panel c, RV12 R-wave triggered pacing is discontinued, leading to an increase of alternans voltage and K score (alternans voltage, ϳ5-fold average increase compared with alternans suppression, P Ͻ 0.000001; and K score , ϳ22-fold average increase compared with alternans suppression, P Ͻ 0.000001). In Fig.  6C , the corresponding electrograms clearly demonstrate a change in T-wave morphology from baseline in sinus rhythm when significant TWA is present (Fig. 6C,a) , to TWA suppression by triggered pacing on every other beat basis (the stimulus artifact from the pacing pulse can be seen and the discrimination between even/odd beats is lost, panel b) and back to baseline, when significant TWA is manifested again (panel c). These data provide an important proof of concept that adaptive pacing protocols can be used in real time to suppress RA and potentially prevent the formation of a proarrhythmic substrate.
The use of stimulation during the absolute refractory period to control RA is based on a vast body of literature investigating the use of nonexcitatory stimulation for cardiac contractility modulation. It has been shown in computer simulations (50) and experimental studies that stimulation during the absolute refractory period is capable of controlling APD. Specifically, pacing stimuli applied during the early absolute refractory period appear to modulate transient outward current (32), A marked elevation in alternans voltage and Kscore is observed during several minutes before VF, demonstrating that these markers can be accurately measured immediately before the onset of arrhythmia and may be used as a trigger to initiate "upstream" antiarrhythmic therapy.
which may lead to further activation of the L-type Ca 2ϩ channel and modulation of calcium transients (32) . Therefore, the use of subthreshold stimulation to control APD and RA may share common mechanisms with the pathogenesis of RA at the cellular level. Beyond adaptive pacing protocols, detection of RA by implantable devices may also be coupled to other forms of therapy. For instance, there is significant interest in coupling microelectromechanical systems to implantable devices to facilitate localized delivery of pharmacological agents for treating various aspects of chronic heart failure (i.e., neurohormonal antagonists, diuretics, antiarrhythmic agents) (54) . It is conceivable that timely and potentially localized delivery of antiarrhythmic agents may also be capable of suppressing RA and restabilizing the electrical substrate.
Conclusions
Although sarcolemmal ionic currents may contribute to alternans under certain circumstances, the prevailing hypothesis of RA is that dynamic subcellular perturbations in intracellular Ca 2ϩ homeostatic mechanisms occurring on a beat-tobeat basis give rise to [Ca 2ϩ ] i alternans, which in turn gives rise to APD alternans and electrocardiographic alternans. At Fig. 6 . Utility of R-wave triggered pacing during the absolute refractory period to suppress spontaneously occurring alternans during acute myocardial ischemia. Alternans voltage (A, blues lines) and Kscore (B, blue lines) are plotted for the triangular intracardiac bipolar lead configuration CS2CS7, CS2LV3, and CS2LV7 in a coronary balloon occlusion model that demonstrates spontaneous alternans. R-wave triggered pacing is delivered from the RV apex (RV12; amplitude, ϩ4 mA; pulse width, 10 ms; and coupling to R wave, 10 ms). a: Spontaneously occurring alternans is visible at baseline during acute ischemia. b: R-wave triggered pacing is delivered from RV12 on every even beat resulting in a suppression of spontaneously occurring alternans. c: R-wave triggered pacing is discontinued and both alternans voltage and Kscore increase to the baseline level during acute ischemia. Transitions a to c occur at times marked by dashed vertical black lines, whereas the red horizontal lines during each intervention indicate the mean value of the alternans voltage and Kscore during that intervention. C: ECG morphology changes during the above described interventions. a: Visible T-wave alternans (TWA) at baseline. b: R-wave triggered pacing delivered from RV12 on every even beat decreases the alternans level. c: Triggered pacing is discontinued and TWA again becomes visible during sinus rhythm. The median odd (red)/even (blue) beats in a 128-beat sequence of the triangular intracardiac bipolar lead configuration CS2CS7, CS2LV3, and CS2LV7 during each intervention are shown. These data demonstrate that triggered pacing during the absolute refractory period can be used to suppress alternans and may serve as an opportunity to deliver upstream therapy to prevent the clinical onset of arrhythmia. the whole heart level, the presence of discordant APD alternans is associated with increased spatial dispersion of refractoriness, wave-front fractionation, and, under certain circumstances, the onset of reentrant arrhythmias. This paradigm suggests that rather than being merely associated with medium-and longterm risk of VTE/SCD, surges in RA may play a more proximate role in creating the conditions necessary for acute arrhythmogenesis. The temporal association between RA and acute arrhythmia susceptibility may also have important clinical implications for early detection of impending arrhythmias and for guiding upstream antiarrhythmic therapies.
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